Sulfonamides and sulfones in dermatologic therapy.
D000818:Animals; D002602:Chancroid / Q000188:drug therapy; D003235:Conjunctivitis, Inclusion / Q000188:drug therapy; D003622:Dapsone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003874:Dermatitis Herpetiformis / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced; D051379:Mice; D009617:Nocardia Infections / Q000188:drug therapy; D011711:Pyoderma / Q000188:drug therapy; D051381:Rats; D012871:Skin Diseases / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014141:Trachoma / Q000188:drug therapy
D013449:Sulfonamides; D003622:Dapsone